Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Toxicon ; 46(8): 921-6, 2005 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-16263148

RESUMO

Acute pancreatitis (AP) is an inflammatory disease of the pancreas characterized by local inflammation and extrapancreatic effects such as lung injury. Secretory phospholipases A(2) (PLA(2)s) have been implicated in triggering AP, but their exact role to evoke AP is largely unknown. Therefore, we have tested the ability of sPLA(2)s to induce AP in rats, using venom sPLA(2)s with residual or high enzymatic activity (bothropstoxin-II and Naja mocambique mocambique venom PLA(2), respectively), as well as sPLA(2) devoid of catalytic activity (piratoxin-I). The injection of Naja m. mocambique venom PLA(2), bothropstoxin-II or piratoxin-I (300 microg/kg each) into the common bile duct increased significantly the pancreatic plasma extravasation and myeloperoxidase activity. The lung myeloperoxidase and serum amylase were also increased for all groups, although the Naja mocambique mocambique venom PLA(2) induced higher lung myeloperoxidase and serum amylase values, compared with piratoxin-I and/or bothropstoxin-II. Histopathology of pancreas and lungs in piratoxin-I-injected rats showed interstitial oedema in both tissues, and neutrophil infiltration with acinar cell necrosis in pancreas. In conclusion, sPLA(2)s induce AP in rats and the catalytic activity is not essential to induce the local effects in pancreas, although it appears to contribute partly to the remote lung injury.


Assuntos
Venenos Elapídicos/química , Pulmão/patologia , Pâncreas/patologia , Pancreatite Necrosante Aguda/induzido quimicamente , Fosfolipases A/toxicidade , Amilases/sangue , Análise de Variância , Animais , Venenos de Crotalídeos , Venenos Elapídicos/toxicidade , Fosfolipases A2 do Grupo II , Pulmão/efeitos dos fármacos , Pâncreas/efeitos dos fármacos , Peroxidase/metabolismo , Fosfolipases A/química , Ratos , Proteínas de Répteis
2.
Toxicon ; 41(7): 823-9, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12782082

RESUMO

The ability of the phospholipases A(2) (PLA(2)s) from Crotalus durissus cascavella, Crotalus durissus collilineatus and Crotalus durissus terrificus venoms and crotapotin to increase the vascular permeability in the rat skin as well as the contribution of both mast cells and sensory C-fibers have been investigated in this study. Vascular permeability was measured as the plasma extravascular accumulation at skin sites of intravenously injected 125I-human serum albumin. Intradermal injection of crotalic PLA(2)s (0.05-0.5 microg/site) in the rat skin resulted in dose-dependent increase in plasma extravascular whereas crotapotin (1 microg/site) failed to affect this response. Co-injection of crotapotin (1 microg/site) did not modify the increased vascular permeability induced by the PLA(2)s (0.05-0.5 microg/site). Previous treatment (30 min) of the animals with cyproheptadine (2 mg/kg, i.p.) markedly reduced PLA(2) (0.5 microg/site)-induced oedema. In rats treated neonatally with capsaicin to deplete neuropeptides, the plasma extravasation induced by all PLA(2)s (0.5 microg/site) was also significantly reduced. Similarly, the tachykinin NK(1) receptor antagonist SR140333 (1nmol/site) significantly reduced the PLA(2)-induced oedema. In addition, the combination of SR140333 with cyproheptadine further reduced the increased plasma extravasation by PLA(2) from C. d. cascavella venom, but not by PLA(2) from C. d. terrificus and C. d. collilineatus venoms. Our results suggest that increase in skin vascular permeability by crotalic PLA(2)s is mediated by activation of sensory C-fibers culminating in the release of substance P, as well as by activation of mast cells which in turn release amines such as histamine and serotonin.


Assuntos
Venenos de Crotalídeos/toxicidade , Edema/induzido quimicamente , Mastócitos/efeitos dos fármacos , Fibras Nervosas Amielínicas/efeitos dos fármacos , Fosfolipases A/toxicidade , Pele/efeitos dos fármacos , Animais , Permeabilidade Capilar/efeitos dos fármacos , Venenos de Crotalídeos/administração & dosagem , Crotalus , Crotoxina/administração & dosagem , Crotoxina/toxicidade , Relação Dose-Resposta a Droga , Injeções Intradérmicas , Masculino , Fosfolipases A/administração & dosagem , Ratos , Ratos Wistar
3.
Neurosci Lett ; 318(3): 158-62, 2002 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-11803123

RESUMO

The leukocyte migration induced by Phoneutria nigriventer spider venom (PNV) has been investigated in rats using the pleurisy model. Intrapleural injection of PNV (10-100 microg/cavity) caused a dose- and time-dependent leukocyte accumulation. The bradykinin B(2) receptor antagonist Hoe 140 (0.5 mg/kg) substantially inhibited PNV-induced cell accumulation, whereas the angiotensin-converting enzyme inhibitor captopril (2 mg/kg) potentiated by 80% this effect. The non-specific kallikrein inhibitor aprotinin and the plasma kallikrein inhibitor soybean trypsin inhibitor greatly reduced PNV-induced leukocyte migration, whereas the selective tissue kallikrein inhibitor P(ac)-F-S-R-EDDnp failed to affect PNV-induced responses. Treatment of rats with capsaicin (50 mg/kg) at the neonatal stage resulted in 67% inhibition of the PNV-induced cell migration. The neurokinin NK(1) receptor antagonist SR140333, but not the NK(2) receptor antagonist SR48968, reduced by 55% venom-induced cell accumulation. We conclude that bradykinin generation is involved in the PNV-induced pleural leukocyte migration in rats, where it can directly activate sensory nerves contributing to a neurogenic inflammatory mechanism.


Assuntos
Bradicinina/metabolismo , Quimiotaxia de Leucócito/efeitos dos fármacos , Inflamação Neurogênica/induzido quimicamente , Neurônios Aferentes/efeitos dos fármacos , Pleura/inervação , Pleurisia/induzido quimicamente , Venenos de Aranha/toxicidade , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Animais , Aprotinina/farmacologia , Benzamidas/farmacologia , Bradicinina/farmacologia , Antagonistas dos Receptores da Bradicinina , Capsaicina/farmacologia , Quimiotaxia de Leucócito/fisiologia , Relação Dose-Resposta a Droga , Leucócitos/efeitos dos fármacos , Leucócitos/imunologia , Leucócitos/metabolismo , Masculino , Inflamação Neurogênica/metabolismo , Inflamação Neurogênica/fisiopatologia , Antagonistas dos Receptores de Neurocinina-1 , Neurônios Aferentes/metabolismo , Piperidinas/farmacologia , Pleura/efeitos dos fármacos , Pleura/fisiopatologia , Pleurisia/metabolismo , Pleurisia/fisiopatologia , Quinuclidinas/farmacologia , Ratos , Ratos Wistar , Receptores da Bradicinina/metabolismo , Receptores da Neurocinina-1/metabolismo , Proteínas de Soja/farmacologia , Inibidores da Tripsina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA